Dashboard
Analysis
Charting
Screener
Resources
Settings
NasdaqGS-META
Mar '15
Dec '16
Sep '18
Jun '20
Mar '22
Dec '23
Sep '25
Trailing Valuation
Stock Price
734.4
738.1
576.4
585.5
572.4
504.2
Total Shares Outstanding
2,521
2,516
2,523
2,534
2,524
2,533
Market Cap
1,851,372
1,857,034.4
1,454,156.3
1,483,682.3
1,444,838.6
1,277,189.3
Total Enterprise Value (TEV)
1,857,984
1,859,523.4
1,433,445.3
1,454,927.3
1,422,985.6
1,257,100.3
Dividend Yield
0.1%
Buyback Yield
2.4%
2.6%
3%
3.3%
3.2%
Debt Paydown Yield
0.2%
-0.6%
Shareholder Yield
2.5%
2.7%
3.1%
3.5%
P/S
9.8
10.4
8.5
9
9.2
P/Gross Profit
11.9
12.7
11
11.4
10.5
P/E
32.4
26.7
22.5
24.5
27
25.7
Earnings Yield
3.7%
4.4%
4.1%
3.9%
P/OCF
17.2
18.2
15.1
16.2
17.5
16.3
P/FCF
41.3
37
27.8
27.4
27.6
FCF Yield
3.6%
P/B
9.5
7.9
8.1
8.8
EV/Sales
8.4
9.1
EV/Gross Profit
12
10.3
10.8
11.2
EV/EBITDA
18.7
19.5
16.1
17.1
18.6
EV/EBIT
22.7
23.6
19.6
21
22.8
21.4
EV/OCF
17.3
14.9
15.9
16
EV/FCF
41.4
37.1
26.9
27.2
25.3
Dividends
DPS
0.5
Payout Ratio
49.1%
7.2%
8%
6.1%
8.1%
9.4%
Margins
Gross Profit Margin
82%
82.1%
81.7%
81.8%
81.3%
Operating Margin
40.1%
43%
41.5%
48.3%
42.7%
38%
EBITDA Margin
49.8%
52.2%
50.7%
57.5%
52.7%
47.3%
Net Profit Margin
5.3%
38.6%
39.3%
43.1%
38.7%
34.5%
Effective Tax Rate
87.5%
10.7%
9.5%
11.5%
12%
10.9%
Pre-Tax Profit Margin
42.3%
43.2%
43.4%
48.7%
43.9%
Free Cash Flow Margin
21.8%
19%
26.2%
28%
40.6%
28.7%
OCF / Sales
58.5%
53.8%
56.8%
57.8%
60.9%
49.6%
OCF / Net Income
1,107.4%
139.4%
144.4%
134.3%
157.6%
143.9%
FCF / OCF
37.2%
35.3%
46.1%
48.5%
66.6%
FCF / Net Income
412.3%
49.2%
65.1%
105%
83.2%
FCF / EBITDA
43.8%
36.4%
51.7%
77%
60.6%
Capital Efficiency
Return on Invested Capital
1.3%
9.6%
9.3%
12.8%
9.9%
9%
Return on Assets
0.9%
7%
6.3%
8.2%
6.5%
Return on Equity
1.5%
10.4%
12.4%
10.2%
Return on Total Capital
2.8%
14.4%
25.9%
12.9%
11.9%
Return on Capital Employed
8.4%
8.9%
10.6%
8.5%
7.8%
Return on Tangible Assets
1%
7.6%
7.3%
6.8%
Receivables Turnover
3.2
3.1
3
2.9
Days Sales Outstanding
114
119.3
120.5
125.1
124.3
126.2
Payables Turnover
1.2
1.3
1.4
2.3
Days Payables Outstanding
306.4
289
296.4
258.8
297.6
156.5
Cash Conversion Cycle
-192.4
-169.6
-175.9
-133.7
-173.3
-30.3
Asset Turnover
0.2
Fixed Asset Turnover
0.3
0.4
Operating Cycle
CapEx to OCF
0.6
CapEx to Revenue
CapEx to Depreciation
3.8
3.3
2.1
2.2
Financial Health
Total Debt
51,060
49,560
49,519
49,060
49,047
37,991
Net Debt
6,612
2,489
-20,711
-28,755
-21,853
-20,089
Current Ratio
2
2.7
2.8
Quick Ratio
1.7
2.5
2.6
Cash Ratio
Debt Ratio
Assets to Equity
1.6
1.5
Cash Flow to Debt Ratio
Long-term Debt to Assets
Intangibles to Total Assets
0.1
Net Current Asset Value
-36,660
-26,061
-4,957
6,628
-812
2,956
Goodwill / Assets
Debt / Equity
Total Debt / Capitalization
1
Long Term Debt / Capitalization
Long-Term Debt / Equity
Net Debt / EBITDA
-1
-1.1
Per Share
Revenue per Share
19.9
18.5
15.6
15
Basic EPS
1.1
7.3
6.6
8.2
6.2
5.3
Diluted EPS
7.1
6.4
8
6
5.2
Book Value per Share
75.5
75.9
71.4
70.3
63.3
60.1
Tangible Book Value per Share
67.2
67.9
63.5
62.3
55.3
52.1
Cash per Share
18.3
27.1
29.9
27.3
22.3
Operating Cash Flow per Share
11.7
9.9
9.3
7.4
Free Cash Flow per Share
4.3
3.5
6.3
CapEx per Share
5
5.6
Weighted Avg. Shares Outstanding
2,517
2,518
2,527
2,529
Weighted Avg. Shares Outstanding Diluted
2,572
2,570
2,590
2,599
2,600
2,610
Common Size
R&D to Revenue
29.6%
27.2%
25.2%
27.5%
27%
SG&A to Revenue
8.3%
16.3%
Stock-based Comp to Revenue
10.8%
9.8%
8.8%
10.5%
11.8%
